Kintor Pharmaceutical Ltd
OTC:KNTPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Kintor Pharmaceutical Ltd (KNTPF) under the Base Case is USD per share.
Compared with the current market price of 0.1567 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Kintor Pharmaceutical Does
Kintor Pharmaceutical Ltd is a drug development company that focuses on small-molecule medicines, especially treatments that act on hormone-related and cancer-related pathways. Its main work is to discover, test, and advance drug candidates through preclinical and clinical development, rather than run a broad commercial drug business. The company is still centered on research and development, so its value comes from building a pipeline of potential medicines.
- Headquarters
- China CN
- Employees
- 123
- IPO date
- May 22, 2020
Earnings Waterfall
Kintor Pharmaceutical Ltd
What is the Intrinsic Value of one KNTPF stock?
The intrinsic value for Kintor Pharmaceutical Ltd (KNTPF) under the Base Case is USD.
Is KNTPF stock undervalued or overvalued?
Compared with the current market price of 0.1567 USD, the stock appears .
